Dermatology Times' Weekly Crossword: AAD Annual Meeting Insights Edition

Welcome to Dermatology Times' Weekly Crossword, where dermatology knowledge meets fun! Each week, we curate a selection of words and terms pulled directly from the latest news in the dermatology world. Whether it's breakthrough treatments, new research findings, or emerging trends, this crossword serves as both a challenge and an opportunity to reinforce your expertise in the field.

This special edition features highlights from our coverage of the 2025 American Academy of Dermatology (AAD) Annual Meeting.

For more in-depth insights, don't forget to check out our Weekly Roundup, where we break down the most important stories and updates from the past week. And to stay ahead of the curve and prepare for future crosswords, make sure to follow our content throughout the week.

Try out either our interactive crossword or a static/non-interactive version below.

Interactive Crossword

This crossword was created with CrosswordLabs.com.

Static/Non-Interactive Crossword

Across

3. Type of birthmark discussed for emerging therapies.

4. Treatment extending symptom-free periods in atopic dermatitis.

5. Topical cream with phase 3 updates presented for prurigo nodularis.

6. A biologic discussed for its role in treating inflammatory skin diseases like psoriasis and hidradenitis suppurativa.

8. JAK inhibitor showing rapid hair regrowth in adolescents with alopecia areata.

9. Chronic skin condition with multiple abstracts reviewed, including 5 year data.

Down

1. Drug with efficacy and safety data presented for pyoderma gangrenosum.

2. Phase 3 trials for this drug showed promise in treating plaque psoriasis.

7. Drug discussed for improving itch and skin pain in atopic dermatitis.

For answers to this week's puzzle, check out next week's edition of the Dermatology Times Sunday Crossword.

Answers from our March 2, 2025 puzzle: [Across: 3 - depression; 4 - melasma; 5 - VR; 6 - telehealth; 7 - nemolizumab; 8 - mucin; 9 - rosacea; Down: 1 - sunscreen; 2 - roflumilast; 5 - vitiligo]